Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 30, 1997

View Archived Issues

Oral and nasal sumatriptan studied for migraine

Clinical results presented for Knoll's PEG-hirudin

Clinical pharmacokinetics and safety reported for Sankyo's MAO-A inhibitor

Clinical pharmacokinetics and bradycardic activity of S-16257

Pentoxifylline demonstrates gastroprotective effects in patient study

First combination anti-HIV drug approved in U.S.

Symphony discloses AMPA antagonists

Inhibitors of sCD23 production developed at SmithKline Beecham

Zeneca presents new antibacterials active against resistant pathogens

Na+/K+-exchange inhibitors from Fujisawa

Rhone-Poulenc Rorer discloses new AMPA/NMDA receptor antagonists

Antiviral thienoxazinones prepared at SKB

LY-333334: new bone anabolic agent from Lilly

PathoGenesis presents new antimycobacterial agents

Alza to market IVAX urology products in U.S., Canada

Intron A/ribavirin combination for HCV: preliminary phase III results

Seroquel cleared for marketing in U.S.

Amgen to emphasize calcimimetics program; preliminary phase II results reported for R-568

LF-08-0299 both prevents and reverses kidney rejection in dogs

Patient recruitment for verteporfin phase III trials exceeds goals

New class of antifungal agents developed at Glaxo Wellcome

SNX-111 study in head trauma resumed

Bayer evaluates novel heteroaryl oxazolidinones

Pfizer seeks U.S. and European approval for Viagra

Techniclone submits IND for malignant glioma

Clinical results on neuraminidase inhibitor presented at ICAAC

Inex seeks Canadian approval to commence Onco TCS trials for lymphoma

Warner-Lambert reports dihydropyrone HIV protease inhibitors

Canadian regulatory review of modafinil continues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...